All In MedTech

FDA Clearance Tracker · P120016-S029

Vascade Vascular Closure System (VCS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 1, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P120016-S029
Device name
Vascade Vascular Closure System (VCS)
Applicant location
Santa Clara, CA
Received
Sep 2, 2022
Decided
Mar 1, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P120016

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

Approval for the following changes:1) Increase in disc deployment diameter from 23F to 25F;2) Increase in collagen mass from 12 mg to 19 mg;3) Modifications to certain device components to accommodate the new disc deployment diameter and collagen mass; and4) Modifications to the Instructions for Use to reflect the changes in device design.

Source documents

Other decisions for Cardiva Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.